| Latest Immupharma Plc News Headlines |
| Date | Time | Source | |
| 10/19/2009 | 5:31AM | RNSNON | 'Best Technology 2009' Award at the AIM Awards
TIDMIMM
RNS Number : 9985A
Immupharma PLC
19 October 2009
?
+------------------------------------+------------------------------------+
| FOR IMMEDIATE RELEASE | 19 OCTOBER 2009 |
+------------------------------------+------------------------------------+
ImmuPharma... More...>> |
| 10/09/2009 | 5:14AM | UKREG | Appointment of Joint Broker
TIDMIMM
RNS Number : 5242A
Immupharma PLC
09 October 2009
?
+------------------------------------+------------------------------------+
| FOR IMMEDIATE RELEASE | 9 OCTOBER 2009 |
+------------------------------------+------------------------------------+
ImmuPharma... More...>> |
| 09/29/2009 | 2:00AM | UKREG | Interim Results
TIDMIMM
RNS Number : 8000Z
Immupharma PLC
29 September 2009
?
+------------------------------------------+------------------------------------------+
| For Immediate Release | 29 September 2009 |... More...>> |
| 09/21/2009 | 4:55AM | RNSNON | 8th Annual Bio Investor Forum
TIDMIMM
RNS Number : 3723Z
Immupharma PLC
21 September 2009
?
+------------------------------------+------------------------------------+
| For Immediate Release | 21 September 2009 |... More...>> |
| 09/17/2009 | 2:00AM | RNSNON | JMP Healthcare Focus Conference
TIDMIMM
RNS Number : 1930Z
Immupharma PLC
17 September 2009
?
+------------------------------------+------------------------------------+
| FOR IMMEDIATE RELEASE | 17 SEPTEMBER 2009 |
+------------------------------------+------------------------------------+
ImmuPharma... More...>> |
| 07/24/2009 | 7:12AM | UKREG | Result of AGM
TIDMIMM
RNS Number : 2504W
Immupharma PLC
24 July 2009
?
+----------------------------------------+----------------------------------------+
| For Immediate Release | 24 July 2009 |... More...>> |
| 07/23/2009 | 11:17AM | UKREG | Directors' Dealings
TIDMIMM
RNS Number : 2020W
Immupharma PLC
23 July 2009
?
+----------------------------------------+--------------------------------------------+
| For Immediate Release | 23 July 2009 |... More...>> |
| 06/30/2009 | 2:00AM | UKREG | Annual Report and Accounts
TIDMIMM
RNS Number : 7193U
Immupharma PLC
30 June 2009
?
+------------------------------------+------------------------------------+
| For Immediate Release | 30 June 2009 |
+------------------------------------+------------------------------------+
ImmuPharma PLC... More...>> |
| 06/24/2009 | 2:00AM | UKREG | Preliminary Results
TIDMIMM
RNS Number : 3938U
Immupharma PLC
24 June 2009
?
+-----------------------------------------+-----------------------------------------+
| FOR IMMEDIATE RELEASE | London, 24 June 2009 |... More...>> |
| 06/17/2009 | 2:01AM | RNSNON | Piper Jaffray Europe Conference
TIDMIMM
RNS Number : 9932T
Immupharma PLC
17 June 2009
?
+------------------------------------+------------------------------------+
| For Immediate Release | 17 June 2009 |
+------------------------------------+------------------------------------+
ImmuPharma PLC... More...>> |
| 03/23/2009 | 3:01AM | UKREG | Directors' Dealings
TIDMIMM
RNS Number : 2575P
Immupharma PLC
23 March 2009
?
+------------------------------------+------------------------------------+
| For Immediate Release | 23 March 2009 |
+------------------------------------+------------------------------------+
ImmuPharma... More...>> |
| 02/04/2009 | 7:32AM | UKREG | Share Options
TIDMIMM
RNS Number : 7889M
Immupharma PLC
04 February 2009
?
+--------------------------------------+--------------------------------------+
| For Immediate Release | 4 February 2009 |
+--------------------------------------+--------------------------------------+
ImmuPharma... More...>> |
| 02/02/2009 | 9:33AM | UKREG | Cephalon license exercise
TIDMIMM
RNS Number : 6468M
Immupharma PLC
02 February 2009
?
For Immediate Release
02 February 2009
Cephalon exercises right to license Lupuzor(TM).
ImmuPharma to receive an additional $30m..
ImmuPharma PLC ("ImmuPharma") (LSE:IMM), the specialist drug discovery and... More...>> |
| 01/30/2009 | 2:00AM | UKREG | Successful trial results
TIDMIMM
RNS Number : 5048M
Immupharma PLC
30 January 2009
?
For Immediate Release
30 January 2009
LupuzorTM Phase IIb study
shows a positive result and achieves statistical significance
ImmuPharma PLC (LSE:IMM), the specialist drug discovery and development... More...>> |
| 12/22/2008 | 7:00AM | UKREG | further instalment of grant
RNS Number : 5869K
Immupharma PLC
22 December 2008
For Immediate Release
22 December 2008
ImmuPharma plc
ImmuPharma receives further instalment... More...>> |
| 11/25/2008 | 9:18AM | TFNF | BRIEF-Cephalon, Immupharma in deal for lupus drug
Nov 25 (Reuters) - Cephalon Inc:
* Immupharma ink $15 million option agreement for late- stage
experimental lupus medication
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223
8780))
(For more news, please click here)
COPYRIGHT
Copyright Thomson Reuters 2008... More...>> |
| 11/25/2008 | 5:36AM | TFNF | Glance-STOCKS NEWS EUROPE-ImmuPharma leaps on option deal
STOCKS NEWS Reuters Results diary
Stocks on the move Real-time Equity News
10:20GMT 25 November 2008-ImmuPharma leaps on option deal
---------------------------------------------------------
Shares in British-based ImmuPharma LLC rise 33 percent... More...>> |
| 11/25/2008 | 5:24AM | TFNF | STOCKS NEWS UK SMALL-ImmuPharma leaps on option deal
STOCKS NEWS Reuters Results diary
Europe Real-time Equity News
UK Stocks on the move
UK smallcaps
10:03GMT 25 November 2008-ImmuPharma leaps on option deal... More...>> |
| 11/25/2008 | 3:33AM | TFNF | UPDATE 1-Immupharma signs licence option deal on key drug
LONDON, Nov 25 (Reuters) - British-based ImmuPharma LLC said on Tuesday it
was signing an option agreement with American biopharmaceutical firm Cephalon
for an exclusive, worldwide licence for its experimental Lupus drug Lupuzor.
Cephalon will pay ImmuPharma $15 million upfront under the option deal.
If... More...>> |
| 11/25/2008 | 2:32AM | TFNF | BRIEF-Immupharma signs licence option deal with Cephalon
LONDON, Nov 25 (Reuters) - Immupharma Plc:
* Signs a $15 million option agreement for late- stage experimental lupus
medication with Cephalon
((London Equities Newsroom; +44 20 7542 7717))
(For more news, please click here)
COPYRIGHT
Copyright Thomson Reuters 2008. All rights reserved.
The... More...>> |